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Objective: To evaluate in a rabbit model the hypothesis that (1) the lung 
consumes a significant proportion of the total body oxygen consumption 
(VO2wb), and (2) the pulmonary oxygen consumption (VO2pui) increases 
with acquired lung injuries. 
Method: The oxygen consumption (VO2) of the animal was measured 
simultaneously using two different methods: (1) indirect calorimetry 
which measures the whole body VO2 (VO2wb), and (2) estimation from 
the cardiac output based on the Fick principle (cVO2). Cardiac output was 
determined by the thermodilution method, since the cVO2 does not 
include the oxygen consumption of the lungs (VO2pui), VO2pui could be 
calculated from the difference between VO2wb and cVO2 (VO2wb -
cVO2=VO2p11i). 3 groups of rabbits were studied: (a) healthy controls 
(n=21); (b) rabbits with acute lung damage (AD) induced by 
subcutaneous N-nitroso-N-methylurethane (NNNMU) (n=14) and (c) 
rabbits with chronic lung damage (CD) induced by intratracheal 
bleomycin. 
ii 
Results: In the healthy controls, Mean 土 SD, VO2wb was 26.7 士 5.6 
ml/min, and cVO2 was 25.8 士 5.5 ml/min; In the AD group, VO2wb was 
27.3 土 6.1 ml/min, and cVO2 was 24.8 土 6.1 ml/min; In the CD group, 
VO2wb was 30.2 土 8.0 ml/min, and cVO2 was 24.2±7.4 ml/min. The 
VO2pui in the control group was 3.3 土 lT/o ofthe VO2wb. In AD and CD 
groups, VO2pui increased to 9.7 士 5.2 % and 20.4 士 6.3% of the VO2wb 
respectively. Histopathological examination confirmed the presence of 
acute inflammation and chronic lung damage in the animal in AD and CD 
group respectively. 
Coficlusioti: The lungs normally consumed about 3% of VO2wb. This 
increased to 9.7% in acute and 20.4 % in chronic lung injury. The 
increase in pulmonary VO2 was likely due to increased local metabolism 









F i c k 方法在計算中未有包括肺部耗氧量 
( V 0 2 p u i ) ，故肺耗氧量可從 m V 0 2 & c V C b i g 
求得(爪乂。- CV02 = VO2pu]) 0 
假設：⑴全身耗氧量(V02vvb)有相當部份由肺耗用； 
(幻肺耗氧量隨肺損傷增加。 
結果：急性損傷組(27.3 ± 6.1 @1/0丨。)和慢性損傷組之 
mV02 (30.2 土 &0 爪1/爪1打)與對照組(26.7 士 5.6 ml/min)^ 
若；而(^乂仏在急性損傷組，慢性損傷組與對 
9¾ ^ 0.^¾']為 24.8 土 6.2 ml/min, 24.2 土 6.2 ml/min 及 25.8 
土 5.4 ml/min。肺耗氧量佔全身耗氧量在對照組 
為3.3 ± 2.2 %，而在急性損傷組和慢性損傷組 
為 9.7 土 5.2 % 及 20.4 土 6.3 % � 
結論••正常肺部耗用全身耗氧量之3.3±2.2%，而因急 
性或慢性損傷，肺耗氧量則會增至9.7 ± 5.2 % 
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1 
Introduction 
Bronchopulmonary dysplasia (BPD) is a chronic lung disease 
(CLD) that results from the unresolved or abnormally repaired lung 
damage. This condition occurs most commonly in premature babies who 
have been exposed to high concentrations of inspired oxygen and 
positive-pressure ventilation. Infants with CLD always have increased 
oxygen consumption (Masrkestad et al, 1981; Kao et al’ 1988) and 
energy expenditure (Weinstein et al 1981), and very often with decrease 
of growth rate (Vohr et al, 1982; Yu et al, 1983; Kurzner et a/,1988). For 
a long time, these phenomena was believed to be due to the abnormalities 
impaired mechanical function of the damaged lung, which resulted in 
increase in the work ofbreathing. 
However in 1988, Kao and colleagues observed that resting 
oxygen consumption of CLD patients remained unchanged, even after 
their pulmonary mechanics had been improved by the use of 
bronchodilators (Kao etal, 1988). 
Oxygen consumption is commonly measured by: (1) Indirect 
calorimetry; and (2) thermodilution technique, applying the Fick 
principle. The former involves direct measurement of the inspired and 
2 
expired oxygen, and the latter involves calculation of oxygen from the 
measured cardiac output and oxygen saturation of arterial and central 
venous blood. 
In previous studies, a difference between measured and calculated 
oxygen consumption was always found (Keinanen et al, 1997). 
Furthermore, the measured oxygen consumption was always higher than 
the calculated oxygen consumption and the difference became more 
obvious when there were lung injuries or pneumonia. (Jolliet et al, 1996; 
Light, 1988). 
Since the thermodilution method measures the cardiac output 
through the pulmonary circulation, before entering the lung, it can be 
presumed that the oxygen content difference between arterial and mixed 
venous blood does not include the effect ofoxygen uptake ofthe lung. 
Based on the above observation, I believe that the amount of 
oxygen consumed locally by the lung contributes a significant part of 
total body oxygen consumption, this might become more significant in 
damaged lung. 
3 
Objective the present study 
To evaluate the hypothesis that: (1) oxygen consumption by the 
lung contributes significantly to the total oxygen consumption of the 
body; and (2) acquired lung injury increases the local oxygen 




Chapter 1 A Review of 
Chronic Lung Disease (CLD) 
6 
Literature Revieyv 
1. BPD - an example of CLD 
Bronchopulmonary dysplasia (BPD) was first named and 
described in 1967，when Northway and associates reported the abnormal 
clinical, radiological and pathological findings of the lungs of a group of 
premature newborns who had been subjected to prolonge ventilation 
through endotracheal intubation with high pressures and high oxygen 
concentration p^orthway, 1967). 
It is a common chronic lung disease (CLD), found mostly in 
preterm newborns that require prolonged mechanical ventilation and 
oxygen therapy. Infants with CLD are characterized clinically by chronic 
respiratory distress, hypoxemia and, hypercapnia. Characteristic patchy 
collapse is usually shown on the chest radiograph. 
In most of the cases, BPD is preceded by respiratory distress 
syndrome (RDS), but also the condition may follow other acute 
pulmonary disorders (Philip, 1975; Banerjee et aI, 1972; Pusey et a/, 
1969; Davis & Rosenfeld, 1994). Wilson-Mikity syndrome, pneumonia, 
apnea of prematurity, and meconium aspiration have all been observed 
before the onset o f B P D (Pusey et al, 1969). 
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The definition o fBPD has been subjected to much discussion, and 
different definitions have been suggested by different workers. (Bancalari 
et al, 1979; 0'Brodovich & Mellins, 1985; Shennan et al, 1988; HiFi 
Study Group, 1989,1990; Hack et al, 1991;Hoekstra et al, 1991; Liechty 
et al, 1991; Corcoran et al, 1993; Rojas et al, 1995). As a result, the 
reported incidence of BPD was very variable, ranging between 5 to 80% 
of babies who had received mechanical ventilation (Berg et al, 1975; 
Johnson, 1976; Edwards, 1983; Farrel & Palta, 1986; Boynton, 1988; 
Shennan et al, 1988; Hack et al, 1991; Campbell & McIntoch, 1997). 
2. Pathological change & Clinical presentations 
BPD is a disease of scarring and repairing of lung tissue, which 
affects its growth. Abnormalities of airways, pulmonary vasculature, and 
pulmonary function are found. In CLD neonates, there are muscular 
hypertrophy, bronchospasm, mucosal edema of the bronchioles, and 
excessive airway mucus. These cause luminal narrowing, and increase in 
airway resistance. (Morray et al, 1982; Gerhardt et al, 1987; Kao et al, 
1988; Mallory et al, 1991; Abman et al, 1994; Baldari et al, 1997). 
Moreover, decrease in lung volume, lung compliance, and reduction of 
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maximal forced expiratory flow at functional residual capacity are also 
noticed in infants with CLD (Watt et al, 1977; Godfrey et al, 1983). 
3. Clinical sequel of CLD infants 
Besides chronic respiratory distress and hypoxia, infants with 
CLD have elevated oxygen consumption and energy expenditure, and a 
decrease in growth rate (Markestad & Fitzhardinge, 1981; Weinstein et 
a/, 1981; Vohr etal, 1982; Yu etcd, 1983; Berman et al, 1986; Kao et al, 
1988; Kurzner et al, 1988; Yeh et al, 1988，Kalhan & Denne，1990; 
Casey et al, 1991; Piedboeuf et al, 1991; Westerterp et al, 1991; 
Brownlee et a/，1992; De Gamarra et al, 1992; Abman & Groothius, 
1994; Knopper et a/, 1994; Van Goudoever et aI, 1994; Meer et al, 1996). 
3.1 O2 consumption of CLD infants 
Though the results of clinical studies varied, a number of studies 
have demonstrated a raised oxygen consumption in infants with CLD 
(Kurzner et al, 1988). Weinstein (Weinstein et al, 1981) and Kao ( Kao 
et al, 1988) reported a 25% higher resting VO2 in infants with CLD when 
compared with those in the control group. 
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Pulmonary edema and interstitial fibrosis restrict the elasticity of 
the lung tissues and increase the work ofbreathing, apparently due to the 
elevated airway resistance and decreased lung compliance (Morray et al, 
1982; Kao et al, 1983,1988; Gerhardt et al, 1987; Abman & Groothius, 
1994). This further leads to an increased in oxygen consumption. 
3.1-1 Oxygen consumption 
Oxygen consumption is the total amount of oxygen consumed by 
the body per minute. By estimating arterial oxygen transport (total 
amount of oxygen carried to the tissues), the amount ofoxygen consumed 
by the body per minute can be determined fNunn, 1993). 
3.1'2 Oxygen transportation 
O2 diffuses from the alveoli to the blood in two forms: dissolved 
oxygen in plasma, or in combination with hemoglobin. 
3.1'2a Dissolved O2 
After entering the lung, oxygen moving across the alveolar 
capillary membrane immediately dissolves in plasma. Clinically, it is 
measured as the partial pressure of O2 in arterial blood (PaO2). Factors 
that influence PaO2 level include the gas volume of the lung, the adequacy 
10 
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of alveolar ventilation, the function of inspired oxygen (F102), together 
with the physical characteristics of the affinity of hemoglobin for oxygen. 
3. l-2b Haemoglobin 
Hemoglobin molecule is formed from the heme, an iron-porphyrin 
compound. It is joined to the protein globin, which consists of four 
polypeptide chains. The chains are of two types: alpha and beta. The 
differences in their amino acid sequences give rise to various types of 
human hemoglobin. Oxygen dissolved in plasma is transported in 
reversible chemical combination with the hemoglobin molecule. 
Oxygenation transforms hemoglobin to oxyhemoglobin. 
O2 + Hb < > HbO2 
Deoxygenated Hb Oxyhemoglobin 
Oxyhemoglobin accounts for about 97 to 98 percent ofthe oxygen 




3.2 Energy expenditure of CLD infants 
In 1988 Kurzner hypothesized that an increase in mechanical 
work of breathing (and associated phenomena such as sympathetic 
activity) results in extra energy expenditure in CLD infants. The 
inefficient gas exchange and increased dead space at the level of the 
alveoli may result in an increased minute ventilation. Hence, increases in 
respiratory rate and energy cost per breath could result in a 
disproportionaI increase of mechanical work ofbreathing in CLD infants. 
(Kurzner et al, 1988;Meer et al, 1996). 
Several controlled studies have shown an increased energy 
expenditure (Ee) in infants with CLD (Kurzner et al, 1988; Weinstein et 
cd, 1988; Yeh et al, 1988; De Gamarra et al, 1992). Weinstein (Weinstein 
et al, 1981) observed that the mean resting caloric expenditure of CLD 
infants was llkcal/kg/day higher than that of the control group. 
Piedboeuf and co-workers (Piedboeuf et al, 1991) found a 30% higher 
metabolic rate in CLD patients when compared to newborn infants of 
similar age with normal respiratory function. Kao (Kao et al, 1988) 
documented a 25-50% increase in caloric requirements by the BPD 
infants. With the doubly labeled water technique, Meer and colleagues 
(Westerterp et al, 1991; Meer et al, 1996) reported a 16% increase in the 
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energy expenditure in BPD infants which closely agreed with the 25% 
increase measured by respiratory calorimetry (Yeh et al, 1988; Kalhan & 
Denne, 1990; De Gamarra et al, 1992). 
3.3 Growth rate of CLD infants 
Poor growth or even growth failure is a common problem of 
infants with CLD. However, whether the growth failure is related to the 
increased work of breathing remains controversial (Kao et al, 1988; 
Kurzner et al, 1988). Although body weight is the most affected 
parameter, growth in length (Berman et al, 1986; Kurzner, et a/,1988; 
Casey et al, 1991; Abman & Groothius, 1994), and skeletal growth 
velocity can also be impaired (Yu et a/,1983; Brownlee et cd, 1992; 
Knopper et al, 1994; Van Goudoever et al, 1994). It has been observed 
that somatic growths parameters of CLD children are generally along the 
10山 to 25th percentile (Kurzner et al, 1988; Casey et al, 1991; Abman & 
Groothius, 1994). 
In 1981, Markestad and Fitzhardinge found that the mean weight 
at postterm of 26 infants with CLD was between the third and tenth 
percentile; mean height was at about twenty-fifth percentile in the first 2 
years (Markestad & Fitzhardinge, 1981). Vohr speculated that growth 
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failure in infants with CLD might be related to poor nutritional intake or 
prolonged intravenous feedings (Vohr et al, 1982). 
It was generally believed that growth failure in CLD can be placed 
in one of two categories: inadequate nutritional intake or inadequate 
oxygenation (Kurzner et a/,1988; Abman & Groothius, 1994; Moyer-
Mileur et al, 1996). 
The oxygen consumption and caloric requirements of BPD 
patients are somehow proportional to the severity of the lung disease. In 
1988, Kurzner observed a significant lower lung compliance, higher 
respiratory rate and minute ventilation in CLD infants with growth 
failure, in comparison to CLD infants without growth failure. A careful 
review of caloric intake has been proposed as an important step in 
examining a CLD patient with impaired growth. (0'Brodvich & Mellins， 
1985; Abman& Groothius,1994). 
4. Treatment & Management of CLD infants 
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General management for CLD infants includes O2 therapy, fluid 
restriction, diuretic therapy, bronchodilator and corticosteroid (Ng et al, 
1993). 
Bronchodilators and diuretics have been proved to have additive 
effects on the improvement of pulmonary function in infants with BPD 
(Kao et al, 1983,1987; Patel et al, 1985; McCann et al, 1985; Engelhardt 
et al, 1986). Bronchodilators and diuretics have been used in the 
treatment of CLD to decrease the amount of excess lung fluid and total 
body water (Rooklin et a/,1979; Kao et a/,1983,1984,1987; McCann et 
al 1985; Logvinoff etal, 1985). 
4.1 Diuretics 
Diuretic drugs commonly used in CLD patients are furosemide, 
chlorothiazide, and spironolactone. Both furosemide given intravenously 
and chlorothiazide given orally have been shown to improve pulmonary 
function in infants with CLD (Kao et al, 1983,1984,1987; Najak et al, 
1983; Logvinoff et al, 1985; McCann et al, 1985; Engelhardt et al, 1986; 
Mammel et al, 1987; Rush et al, 1990; Ehrenkaranz & Mercurio, 1992). 
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Besides increasing urine and solute excretion, diuretics also have 
their beneficial effects on lung function. For instance, furosemide and 
some thiazide drugs exert a nitrate-like effect on vascular smooth muscle 
(Davila & Davila, 1981; Mironneau et al, 1981); forosemide given by 
inhalation affects chloride transport in tracheal epithelium (Widdicmobe 
et al, 1983) and dilates constricted airways (Bianco et al, 1988). The 
pulmonary effect of furosemide seems to be independent of its diuretic 
effect, since the medication is able to reduce lung edema even in anephric 
animals (Bland et al, 1978). 
4,2 Bronchodilators 
Theophylline, caffeine, albuterol, and terbutaline have all been 
shown to provide acute therapeutic relief of bronchospasm in CLD 
babies. Theophylline given symptomatically improved airway resistance 
and dynamic compliance, and decreased the work of breathing in 
ventilator-dependent infants with CLD (Rooklin et al, 1979). After 
administration of inhaled p-agonist bronchodilators, such as albyterol, 
infants with CLD exhibited improvement in pulmonary function test 




Studies on the use of dexamethasone have authenticated 
improvement of lung function and compliance in CLD infants within 
days; this effect appeared to facilitate weaning the infants from assisted 
ventilation and intubation (Najak et al, 1983). The benefits of 
dexamethasone seemed to be immediate but short lived. The duration of 
mechanical ventilation appeared to be shortened, but not the duration of 
O2 supplementation (Korones, 1996). There was no effect on mortality or 
the duration of hospital stay, (Avery et al, 1985; Cummings, D'Eugenio 
& Gross 1989; Harkavy et al, 1989; Collaborative Dexamethasone Trial 
Group 1991). The use of dexamethasone was associated with a number of 
adverse effects, such as infection, hyperglycemia, hypertension, intestinal 
perforation, and suppression of the adrenal glands. 
As a result of the short-term benefits, the postnatal use of 
dexamethasone for the prevention or the amelioration o f C L D has become 
widespread in NICUs (Farrell & Fiascone，1997) 
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5. Interpretations of the observed phenomena, why does CLD 
impairgwwth? 
5,1 The traditional view 
It has been widely accepted that the raised oxygen consumption, 
energy expenditure and decreased growth rate noticed in CLD patients are 
due to their increased work ofbreathing (WoIfson et al, 1984; Kurzner et 
al, 1988;Meer etal, 1996). 
The total work of breathing is the sum of the mechanical work 
done in moving the lungs, the respiratory gases, the thorax, the 
diaphragm, and the chest wall during the breathing cycle. Mechanical 
work of the lungs may be greatly increased in obstructive airway, and in 
diffused pulmonary fibrosis. When the mechanical work of breathing 
increases, the oxygen (O2) requirement of the respiratory muscles rises, 
leading to greater total body oxygen consumption (VO2). 
Since both diuretics and bronchodilators improved the pulmonary 
function, it was expected that a reduction of VO2 could be achieved in 
CLD infant by treating them with these medications. 
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5.2 Disagreement with the traditional view 
In 1988, Kao and colleagues studied the effect of bronchodilator 
treatment on VO2 in a group of CLD infants (Kao et al, 1988). To their 
surprise, the treated infants showed a significant improvement in the lung 
mechanics but no change in VO2. This important discovery overthrew the 
assumption that increased VO2 and energy expenditure were due to 
increased work of breathing, and led to the need for the exploration of an 
alternative explanation. 
19 
Chapter 2 Measurement of 
Oxygen Consumption 
20 
Measurement of VO2 
Oxygen consumption may be measured either as the loss of 
oxygen from a closed rebreathing system or, by the subtraction of the 
quantity of oxygen exhaled from the amount inhaled. Methods usually 
used in measuring oxygen consumption include invasive (e.g. Fick O2 
consumption method; dye-dilution method; thermodilution method) and 
non-invasive techniques (e.g. Indirect calorimeter, Doppler 
ultrasonography; Transthoracic Electrical Bioimpedance). 
1. Invasive measurement of VO2 
By using the Fick principle, O2 consumption could be estimated 
using the amount of oxygen transported in the patient's blood as an 
indicator. VO2 is then calculated as the difference between the arterial and 
mixed venous oxygen contents multiplied by the patient's cardiac output. 
1.1 Cardiac output 
Cardiac output is the quantity of blood delivered by the heart to 
the systemic circulation over time, that is, the volume of blood pumped 
by the left ventricle into the aorta each minute. It is the product of stroke 
volume (the amount of blood ejected by the heart per beat) multipled by 
heart rate. 
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Cardiac output is an important measurement in the overall 
assessment ofcardiovascular function and is essential to the calculation of 
stroke volume, blood oxygen transport, and intrapulmonary shunt as well 
as pulmonary and systemic vascular resistance. It is affected by a number 
of factors including preload, aflerload, myocardial contractility, and 
muscular synchrony. 
1.2 Fick method 
The Fick principle is one of the classical methods for the 
determination of cardiac output. Because the tissue oxygen consumption 
cannot be directly measured, so it can only be calculated, taking into 
account cardiac output, hemoglobin level, and arterial and mixed venous 
oxygen saturation. The rationale of the Fick principle is that ifthe amount 
ofoxygen transported to tissues, and the amount returning to the heart are 
known, the amount of oxygen consumed can be determined. 
In 1870 Adolph Fick, the German physiologist stated that: 
"During any interval of time, the amount of a substance entering a given 
compartment in the inflowing blood must be equal to the quantity of the 
substance being removed from the blood by the compartment plus the 
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quantity of the substance leaving in the outflowing blood." (Fick, 1870) 
{Fig 1.2-1) 
The Fick principle can be applied to calculate oxygen consumption as 
follows: 
O2 consumption (VO2)(ml/min) 
Cardiac output (CO) (l/min)= 
Difference between arterial and mixed 
venous oxygen content (ml/1) 
O2 consumed (VO2) 
C 0 = 
[(arterial O2 content)-(mixed venous O2 content in the right atrium)] 
or, 
VO2 
CO = [1] 
CaO2 - CvO2 
where CaO2= arterial O2 content, CvO2 = mixed venous O2 content 
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Since, 
O2 content (ml/L) ={[O2 saturation (%)] x [amount ofO2 per ml 
combined with Hb (ml/g/L)] 
+ (O2 per ml dissolved in plasma (ml/L), 
or 
O2 content = [(O2 saturation) x (1.36*Hb)] + O.OO3PO2， 
Since each gram ofhuman Hb is combined with 1.36ml ofO2 when fully 
saturated (Greogory, 1974)，and the amount of oxygen dissolved in 
plasma is 0.003ml/L/Kpa, 
therefore， 
Arterial O2 content (CaO2) = (SaO2xlJ6Hb) + O.OO3PaO2 
Mixed-venous O2 content (CvO2) = (SvO2xl.36Hb) + O.OO3PvO2 
Thus 
VO2 
CO = — - [ 2 ] 
[(SaO2x 1.36Hb)+0.003Pa02 ]-[(SvO2 x 1.36Hb)+0.003Pa02] 
By rearranging equation [1] and [2]: 
VO2 = CO X (CaO2 - CvO2) 
or, 
VO2 = CO X {[(SaO2 X 1.36Hb) + O.OO3PaO2] 
-[(SvO2 xl.36Hb) + O.OO3PvO2]} 
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/J Advantages & Disadvantages of Fick method in estimating VO2 
When the procedure is performed correctly, The Fick method is 
the most accurate way of measuring cardiac output, especially when the 
cardiac output is low, and is widely accepted as a "gold standard" for 
cardiac output determination. 
However, this method has a number of limitations (Hillis et al, 
1985; Mahutte et al, 1994). It is invalid in the presence of intracardiac or 
intrapulmonary shunts. The patient must be in stable states, so that a 
steady metabolic state is achieved, and the method is not suitable in 
critically ill patients. The procedure requires highly skilled personnel to 
perform, is time-consuming, and requires meticulous technique. 
Moreover as blood withdrawal from an arterial line and a central venous 
line is required, there is considerable risk of infection. This method does 
not provide easily repeatable or continuous cardiac output measurements 
and the results are not readily available for immediate clinical 
intervention. 
Because of the limitations, the method is usually used in the 
laboratory or research settings, and rarely as a clinical investigation. 
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1.4 Measurement of cardiac output by thermodilution 
Using the Fick method to estimate VO2 requires assessment of 
cardiac output. One of the techniques for measuring cardiac output is the 
thermodilution method. It was first described by Fegler in 1954 (Fegler, 
1954), and was first used in human patients by Branthwaite and Bradley 
at St. Thomas' Hospital in 1968 (Branthwaite & Bradley 1968). However, 
it did not gain widespread acceptance until the development of the 
thermodilution pulmonary artery catheter, by Ganz and coworkers in 
1971 (Ganz etal’ 1971). 
There are three slightly different thermodilution techniques in 
clinical use: cold thermodilution, warm thermodilution and 
transpulmonary thermodilution, all ofwhich use a thermal indicator (cold 
or warm) injected into the right side of the heart, and any change in 
temperature of the blood is detected either in the pulmonary arterial or in 
the aorta. 
During the cold and warm thermodilution, a catheter, with a 
temperature sensor at its tip such as the Swan Ganz catheter is inserted 
via a central vein (usually the intemaljugular ofsubclavian) into the right 
atrium. The tip of the catheter containing the thermistor should lie inside 
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a branch of the pulmonary artery, and the side hole allowing exit of the 
injectate should lie inside the right atrium. Cold or warm normal saline or 
dextrose is injected rapidly via one port of the catheter into the atrium 
through a side-hole near the tip of the catheter. The cold or warm injectate 
mixes with the blood in the right atrium and ventricle before passing into 
the pulmonary artery where the change in temperature is sensed by the 
thermistor. The passage of the blood mixed with the injectate through the 
measurement site creates a curve representing the change in temperature 
over time. The area bound by the curve is inversely proportional to the 
volume of blood passing through the site {fig 1.2-2). Cardiac output is 
then calculated form the temperature-time curve. 
For the transpulmonary thermodilution, the injection catheter is 
placed inside the right atrium. A fine wire thermistor is inserted through 
the femoral or carotid artery into the proximal part of the descending 
aorta, where any change in temperature following injection is detected. 
This method is particularly suitable for studying small animals. 
The thermodilution method is believed to be a "gold standard" for 
cardiac output measurement in subjects without intracardiac or 
intrapulmonary shunts (Riedinger & Shellock，1984). Previous studies 
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reported very good agreement and high correlation between 
thermodilution cardiac output and other techniques, including the 
indocyanine green dye method (Fischer et al, 1978), Doppler 
echocardiography (Christie et al, 1987)，the direct Fick method (Hillis et 
al’ 1985), and more recently, impedance cardiography (Gothshall et al’ 
1989). 
1.4'1 Advantages and Disadvantages of Thermodilution Method 
The thermodilution procedure can be easily and quickly 
performed repeatedly byjust one trained person. It also has the advantage 
of not requiring any blood sampling. 
However, this method does not provide continuous cardiac output 
measurement, and its accuracy decreases while the cardiac output is low 
(Imai et al, 1997) or when there is presence of intracardiac or 
intrapulmonary shunts, tricuspid regurgitation, and possibly severe mitral 
regurgitation (Nishikawa & Dohi, 1993). To insert a catheter into the 
heart poses an infection risk, and the risk of damaging the carotid or 
subclavian arteries. The procedure might also be complicated by 
pneumothorax, dysrrhythmias including ventricular fibrillation, 
perforation of the atrium or ventricle, damage to the tricuspid or 
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pulmonary valves, knotting of the catheter, catheter transection and 
endocarditis. (Buchbinder & Ganz, 1976; Barash et al, 1981; Boyd et al, 
1983; Durand et al, 1995; Eidelmann et al, 1994; Horst et al, 1984; Gore 
et al, 1987; Kinirons & MacSullivan，1996; Robin, 1985,1987,1988; 
Sykes, 1992; van Doom et al, 1994). 
2. Non-invasive measurement of VO2 
By subtracting the quantity of O2 exhaled from the amount 
inhaled, VO2 could be measured non-invasively by a metabolic 
analyzer~the Detatrac II metabolic monitor (Datex Instrumentarium 
Corp., Helsinki, Finland). 
2.1 Metabolic analyzer一-Deltatrac™II 
The Deltatrac is an open system indirect calorimetry designed for 
measurements of VO2 and VCO2 in both spontaneously breathing and 
mechanically ventilated subjects (Merilainen, 1987). The difference 
between the inspired and expired oxygen fractions (F102, FE02) is 
measured with a fast-response paramagnetic differential oxygen sensor 
(OM-101, Datex/Instmmentarium) (Merilainen, 1988). 
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2,2 Paramagnetic sensor 
Oxygen has a magnetic susceptibility, which is 100 times higher 
than other common respiratory gases. This has been used to construct 
analyzers first by Pauling and colleagues, (Pauling et al, 1946) and later 
by Hummel (Hummel et al, 1968). Since O2 molecules in a non-
homogeneous field tend to move to where the field strengths are higher, 
this principle can be used to measure O2 concentrations with a shorter 
response time (150ms). 
3. Measured and calculated oxygen consumption 
Indirect calorimetry measure VO2 directly (mVO2) and the VO2 
estimated by the Fick method is indirect, being calculated from cardiac 
output and the difference between arterial and mixed venous oxygen 
consumption (cVO2). 
3.1 Difference between mVO2 and cVO2 
Despite very carefully controlled experimental conditions, 
differences between mVO2 and cVO2 have always been noticed with 
mVO2 being consistently greater than cVO2. The differences recorded by 
various previous workers were: Keinanen (Keinanen & Takala, 1997): 33 
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ml/min; Jolliet (Jolliet et al, 1996): 25 ml/min.m^; Brandi (Brandi et al, 
1992) : 5 ml/min.m^; Myburgh (Myburgh et a/,1992) : 24 ml/min and 
Smithies (Smithies et al, 1991): 36 ml/min. 
Furthermore, a larger difference between mVO2 and cVO2 had 
been observed where there was damage in the lung such as pneumonia 
(Light et al, 1988) or acute lung injuries (Jolliet et al, 1996). Patients after 
cardiac bypass operation and patients with adult respiratory distress 
syndrome have also been found to have significant difference between 
mVO2 and cVO2 (Takala et al, 1989; Gill et al, 1994). 
4. Summary 
Oxygen consumption can be measured by the thermodilution 
method applying the Fick principle (calculated oxygen consumption, 
cVO2); or by an indirect calorimetry, (measured oxygen consumption, 
mVO2). However, in spite of the reliability ofboth methods, a consistent 
difference between mVO2and cVO2 was always detected, and the mVO2 
was always greater than the cVO2. The difference was appeared to be 
more marked when there were injuries in the lung. 
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Researcher(s) Ymr Subjectofstudy 厂〜— : V O i ^ h % ~ 
Fritts et al 1961 Human /Patient 12 
Fritts et al 1963 Human /Control 0.7 
Fritts et al 1963 Human /Patient 0.95-11.6 
Levinson et al 1987 Human /Patient 16 
Light 1988 Dogs/ Pneumonia 13-15 
Takala et al 1989 Human A'atient 16-24 
Chopin et al 1990 Human /Patient 10 
Smithies et al 1991 Human /Patient 13 
Bizouam et al 1992 Human A^atient 22 
Myburgh et al 1992 Human /Patient 8 
Smithies et al 1992 Human /Patient 27 
Becq et al 1992 Human /Patient 22-40 
Oudemans-van Straaten et al 1993 Humanyl'atient 27-32 
Chiolero et al 1994 Human /Patient 13 
Loer et al 1997 Human A'atient 5 
Table 1.3-1 VO2puim reported in previous literature 
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1. Possible explanations for the difference between m VO2 & cVCh 
1.1 Measurement variabilies and Mathematical errors 
There are various interpretations for the difference between mVO2 
and cVO2. Among the explanations is technical error in the 
measurements. It has been suggested that up to 14% of the total body 
oxygen consumption could result from the variability of the methods used 
(Nunn, 1996). One source of the artifact is mathematical coupling of 
shared variables with the use of Fick method, particularly the cardiac 
output. Variation in cardiac output may also be caused by drugs with 
inotropic effect used in some of the subjects (Russell & Phang, 1994). 
Nevertheless, measurement variability and mathematical errors 
should be random and could not explain the consistent observations of a 
higher mVO2 than cVO2. 
L2 Oxygen consumption of the lung 
Since the Fick method measures the oxygen content of the blood 
in the right atrium before entering the lung, it can be assumed that the 
oxygen content difference between arterial and mixed venous blood does 
not include the effect of local oxygen uptake by the lung tissue. In 
contrast, mVO2 estimated by indirect calorimetry measures VO2 of the 
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entire body including the lungs. Thus the difference between mVO2 and 
cVO2 represents the intrapulmonary oxygen consumption (Keinanen & 
Takala，1997). Moreover, the exaggerated difference between mVO2 and 
cVO2 in subjects with lung damage might be due to an increased 
metabolic rate of the injured lung (Fritts et al, 1961; Fritts et al, 1963; 
Levinson et al, 1987; Light et al, 1988; Takala et al, 1989; Chopin et al’ 
1990; Smithies et al, 1991; Bizouam et al, 1992; Myburgh, 1992; 
Smithies et al, 1992; Nunn et al, 1993; Jolliet et al’ 1996) {Table 1.3-1). 
In 1987, Nunn proposed that the oxygen consumption of the lung 
(VO2puim) could be assessed by the difference between whole-body VO2 
(VO2wb) measured by indirect calorimetry and the values calculated by 
the Fick method. He estimated that lung used up 1-4% of the whole-body 
VO2 (VO2wb) (Nunn, 1987). 
Loer and co-workers reported that the lung depleted about 5% of 
total body oxygen consumption in humans. They measured the pulmonary 
oxygen consumption before and during total cardiopulmonary bypass 
(CPB). As the pulmonary circulation is separated from systemic blood 
flow during this procedure, the contribution of systemic (bronchial) blood 
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flow to pulmonary gas exchange during cardiopulmonary bypass was 
assessed (Loer et al’ 1997). 
1.3 VO2pui ^ith lung damage 
Many studies have demonstrated an increase in body oxygen 
consumption could occur in the presence ofpulmonary infection (Fritts et 
al, 1961, 1963; Levinson et al, 1987; Takala et al’ 1989; Chopin et al, 
1990; Smithies et al, 1991,1992; Bizouam et al’ 1992; Myburgh et al, 
1992; Becq et al, 1992; Oudemans-van et al, 1993). Extensive research 
has shown that infants in whom BPD developed could be distinguished 
from those without BPD by the present of an ongoing inflammatory 
process within the lung that augments and perpetuates lung damage 
(Zimmerman, 1995). If the enhanced VO2 of infected lungs is real, it is 
possible that inflammatory cells such as neutrophils and macrophages 
might play a part. 
!•4 Response of Neutrophils, Macrophages and oxygen 
consumption 
Both the neutrophils and macrophages undergo oxidative 
metabolism. Inflammatory tissues might have increased oxygen 
consumption due to accumulation of the cells and increased phagocytosis. 
37 
Hypothesis 
Moreover, the oxygen consumption of neutrophils increases enormously 
during the "oxygen burst" associated with the formation of oxygen-
derived free radicals. 
Premature infants often require supplemental oxygen as well as 
mechanical ventilation, which may cause inflammatory lung change with 
influx of large number of neutrophils (Ogden, 1984; Merritt et al, 
1981,1983; Bruce et al 1982; Zimmerman, 1995). After the first week, 
the number of neutrophils is greatly reduced in the lungs of babies who 
recovered from RDS completely, but elevated numbers persist in those 
who progress to CLD (Merritt et al, 1981,1983; Ogden, 1984; Bruce et al 
1992; Zimmerman, 1995). The presence of inflammatory cells and 
reparative process in CLD may result in excessive consumption of 




Based on the observations previously described, I have derived the 
following hypothesis: 
(1) Oxygen consumption by the lung contributes significantly to 
the total oxygen consumption of the body. 
(2) Acquired lung injury increases local oxygen consumption by 
the lung. 
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This study is approved by the Ethics Committee of the Chinese 
University of Hong Kong. All personnel involved in this animal 
experiments are holders of the Animal Licence issued by the Department 
of Health, Hong Kong Special Administrative Region. Animal 
experiments in this study were performed in the Lee Hysan Clinical 
Research Laboratory of the Prince ofWales Hospital, Shatin, Hong Kong. 
White New Zealand rabbits were divided into three groups at 
random: healthy control (N), acute lung damage (AD), and chronic lung 
damage (CD) groups. The weight and age of each animal were recorded. 
Lung injuries in AD group were induced with a single subcutaneous dose 
of N-nitroso-N-methylurethane (NNNMU) (12mg/kg) 2-3 days before 
experiment. In the CD group, bleomycin was given intratracheally 
through an endotracheal tube 8 weeks before experiment. In each rabbit, 
oxygen consumption was measured simultaneously by indirect 
calorimetry using a metabolic analyzer (mVO2) and by the thermodilution 
technique applying Fick principle (cVO2). Since the thermodilution 
method samples the oxygen concentration of the blood from the right 
atrium before entering the lung, the difference of mVO2 and cVO2 gives 
the local tissue oxygen consumption of the lung (VO2pui). 
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1. Animals 
44 White New Zealand rabbits were bred and raised in the Animal 
House of the Chinese University of Hong Kong. At 9-32 weeks when 
they were weighing 1.7-4.1 kg, the rabbits were randomized into 3 groups 
(1) healthy control group (N), (2) acute lung damage (AD), and (3) 
chronic lung damage group (CD). 
2, Chemicals used for inducing lung damage 
2.1 A cute damage group 
2.1-1 N-nitroso-N-methylurethane (NNNMU) 
N-nitroso-N-methylurethane (NNNMU) (Pfaltz & Bauer Inc., 
Waterbury) is a potent alkylating agent with marked carcinogenic effect 
on animal tissues. Tumors of the stomach and esophagus have been 
induced by a single oral administration ofthe compound in varies species 
of animals (Schoental et al, 1960). A single subcutaneous injection 
consistently results in acute lung injury in various species of animals 
including rabbit. The damaged lung shows alterations of the endogenous 
surfactant system resembling those in patients with ARDS (Ryan et al, 
1981;Lewis et al, 1990). 
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2.1-2 Administration to rabbits 
In adult rabbits, progressive lung injury over time was noticed 
after a single subcutaneous injection o f N N N M U at a dose of 12mg/kg. 
Severe respiratory distress and cyanosis was obvious by 3 to 4 days, and a 
90% mortality by 4 days was observed (Godwin et al, 1991). Changes of 
ARDS symptoms were evident as early as 1 to 2 days after NNNMU 
injection (Ito et al, 1997). 
On histological examination, the lungs of these animals showed 
microatelectasis, interstitial and alveolar edema, together with hyaline 
membrane formation. There was necrosis of alveolar epithelial cells 
during the acute phase and evidence of regeneration during recovery 
(Ryan et al, 1976，1983). Disaturated phosplatidylcholine (DSPC) and 
phosphatidylglyceral (PG) in alveolar lavage were observed during the 
early phase of injury (Ryan et al, 1981; Liau et al, 1984). In electron 
microscopic studies, there was necrosis of both types of alveolar 
epithelial cells without significant injury to the capillary endothelium 
(Ryan et al, 1981). 
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A major physiological consequence of this injury was a marked 
lessening in lung compliance together with a reduction in lung volume 
(Barrett et al, 1979). This decrease in CL and increase in surface tension 
may be due to a quantitative reduction or qualitative change in lung in 
surfactant, or to a combination of both. Qualitative changes in surfactant 
may be directly caused by the NNNMU, or may be the result of 
denaturation by edema fluid protein (Ryan et al, 1978). 
The lung injury induced by NNNMU has been used as a model for 
ARDS (Ryan et al, 1976; Richardson et al, 1986). In comparing to more 
acute injury models, the NNNMU lung injury model may provide 
information regarding ARDS with a slow evolution of the clinical 
syndrome in contrast to a direct chemical or physical type of injury, such 
as blunt chest trauma or aspiration (Pappert et al, 1996). 
2.2 Chronic damage group 
2.2-1 Bleomycin (BLM) 
BLM consists of a group of antibiotics isolated from Streptomyces 
verticillus. It is used primarily in the treatment of lymphomas, squamous 
cell carcinomas, and testicular tumors (Yagoda et al, 1972). Although the 
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agent is highly effective in the treatment of certain malignancies, skin and 
pulmonary toxicity limits its tolerance by many patients. These adverse 
effects have been noted in both clinical trials (Ichikawa, Nakano & 
Hirokawa, 1969) and animal studies (Thompson et al, 1972; Adamson & 
Bowden, 1974). 
2.2-2 Pulmonary toxicity of Bleomycin 
BLM-induced pulmonary damage is an established model for the 
study of interstitial pneumonitis and pulmonary fibrosis. Whether 
administered subcutaneously (Lazo, Catravas & Gillis, 1981), 
intraperitoneally (Adamson & Bowden, 1974), or intravenously 
(Thompson et al, 1972)，bleomycin induces pulmonary fibrosis in many 
animal species, including humans (Adamson & Bowden, 1974; Comis, 
1978). Intratracheally administered BLM has been shown to induce a 
rapid and predictable pneumonitis, progressing to fibrosis in many species 
of animals (Snider et al, 1978). 
2.2-3 Administration to animals 
In mice, hamsters and rabbits, administration of bleomycin was 
followed by initial phase of alveolitis eventually progressing to a chronic 
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inflammatory process charactered by fibrosis (Adamson & Bowden， 
1974; Aso, Yoneda & Kiklawa, 1976; Comis, 1978). There was an early 
phase of exsudative injury with hyaline membranes formation, interstitial 
and alveolar edema, followed by a chronic phase of diffuse interstitial 
fibrosis (Bellet-Barthas et al, 1983). 
Intratracheal bleomycin (BLM, 10 mg/kg) causes chronic lung 
fibrosis in rabbits. The evolution of fibrosis in the rabbit is slower than in 
other experimental animals. There is cellular and fibrocellular lesions 4 
weeks after B L M administration. Changes in lung content of collagen, 
protein and DNA are evident at 8 weeks after BLM. O'Connor (O'Connor 
et al’ 1986) pointed out that the rabbit model has advantages over others 
for the serial study of lung fibrosis, because of the continuing active 
inflammation and slow progress of fibrosis induced by intratracheal 
BLM. 
In 1988, Shen and coworkers demonstrated a wide spectrum of 
lung injuries in New Zealand white rabbits by using 5U/kg or lOU/kg of 
intratracheal bleomycin with and without oxygen supplementation (Shen 
et al, 1988). The bleomycin-induced interstitial lung disease in the rabbit 
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causing acute lung injury as well as chronic inflammation and fibrosis 
was found on Day 12 and Day 56 respectively (Jellinek et al, 1997). 
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1. Measurement of VO2 & VCCh - DeltatracII™ Metabolic 
analzyer 
The DeltatracIlTM metabolic monitor (Datex Instrumentarium 
Corp., Helsinki, Finland) ifig 2.3-1) is an open system indirect 
calorimetry device designed for the measurement of VO2 and VCO2 in 
both spontaneously breathing and mechanically ventilated patients 
(Stothers et al, 1979). The paramagnetic analyzer of the equipment (OM-
101, Datex) (fig 2.3-2) detects any difference in inspired and mixed 
expired oxygen partial pressures, from which VO2 is calculated. The 
expired CO2 fraction (FEc02) is measured with an infrared CO2 sensor. 
Energy expenditure is calculated from the measured VO2 and VCO2. A 
microcomputer controls a set of magnetic valves for the automatic control 
ofthe absolute F102, F1co2, and gas analyzer baselines. During mechanical 
ventilation the device is connected to the outlet port of the ventilator and 
expired air is collected through a built-in mixing chamber, The mixed 
expiratory gases are then diluted in the mainstream of the constant flow 
generator (fig 2.3-3). F102 and F1c02 are measured from the ventilator's 
inspiratory limb and FEc02 and Feco2 from the mixing chamber. The 
fraction of CO2 in the diluted expiratory gases, downstream from the flow 
generator is also measured. VCO2 is calculated in both canopy and 
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respirator measurements as the product of the constant flow (Q) and 
fraction of CO2 in the diluted expiratory flow {fig 2.3-3 & 23-f): 
VCO2= Q X FEc02 
With the canopy, the VO2 is calculated using the Haldane 
transformation (Merilainen, 1987): 
VO2 = (Q / [1 -F102 ])x (F102 - F E02 - F102 X [FEc02- F1co2]) 
where Q is the constant gas flow, and FE02 and FEc02 the 
fractions of oxygen and CO2 in the mixed expiratory gas flowing through 
the monitor ifig 2.3-3). During respirator measurement, the RQ is 
calculated with the Haldane transformation from the gas fractions: 
R Q = (l-F,02)/{[(F ,02-F E02)/F E02]-F ,02 
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where the pE02 and pEco2 are measured from the mixing chamber 
and then form a constant flow and the concentration of CO2 down stream 
from the mixing chamber in a manner identical to the canopy 
measurement. The VO2 is subsequently calculated from the RQ as: 
V O2= VCO2/ RQ 
The effect of humidity is excluded by balancing all measured 
gases, including the calibration gas, with Nafion tubing (Perma Pure 
Products, Tom's River, NJ). All gas exchange results are expressed in 
STPD. 
2. Measurement of cardiac output — Cardiomax II model 85 
The Cardiomax II model 85 (Columbus Instruments, Ohio) is a 
thermodilution cardiac output computer (fig 2.3-5). During its operation, a 
known ..volume of ice-cold Normal Saline is introduced into the right 
atrium through a central venous catheter. A microprobe (temperature 
sensor) is placed in the subject's aorta to monitor the changes in 
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temperature brought about by the dilution of the injectate in the blood. 
The computer records the temperature changes over time and integrates 
the curve bounded by the dilution curve and the baseline. Cardiac output 
is computed using the following equation: 
(Tblood-Tinj) X Vinj 
Cardiac output = 
Integral of curve 
where: Tbiood is the blood temperature prior to injection (degrees 
°C); and Tinj the injectate temperature ( d e g r e e s � C ) at the time of 
injection; Vinj is the volume of injectate (milliliters). Integral of curve is 
the area bound by Tbiood and the recorded change in temperature over the 
time required for the blood to re-establish T b i � � d . 
Injectate temperature is measured with a platinum probe. It is the 
method of temperature measurement used by the National Bureau of 
Standards. 
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1. N-nitroso-N-methylurethane (NNNMU) Preparation 
0.1 ml o f97% NNNMU solution (Pfaltz & Bauer Inc., Waterbury) 
was first diluted in 0.9ml of 0.15M sodium chloride (NaCl) and then 
further diluted in 6ml of 0.15M sodium chloride to a concentration of 
138.57mg/ml in 7 ml NNNMU solution. 
2. Bleomycin Preparation 
5ml of0.15M sodium chloride solution was drawn into a syringe, 
and injected into an ampoule of bleomycin to dissolve its content. The 
resultant solution was drawn into the syringe before use. 
3. 2.5 % pen tobarbitone Preparation 
lOgm of 25M pentobarbitone powder was weighed and dissolved 
in 100ml of double deionized water. 
4. Animal Preparation 
Adult White New Zealand rabbits were bred and raised in the 
Animal House of the Chinese University of Hong Kong. Thirty adult 
rabbits (19.33 士 6.34 weeks of age) rabbits of either sex weighing 3.28 土 
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0.92 kg were randomized into 3 groups: (1) healthy control group (C), (2) 
acute lung damage group (AD) and chronic damage (CD) group. Their 
weight and age were recorded. 
4.1 Control (Normal) group 
Rabbits in this group were obtained directly from the Animal 
House of the Chinese University ofHong Kong shortly before experiment 
without any prior treatment. 
4.2 Acute lung damage group 
Two to three days before experiment, lung injury in this group 
was induced by a single subcutaneous injection (15mg/kg) of N-nitroso-
N-methylurethane (NNNMU) (Pfaltz & Bauer Inc., Waterbury) (Godwin 
et al, 1997; Ito et al, 1997) at a shaved area of the back. The rabbits were 
kept at the Animal House until the day of experiment. 
4.3 Chronic lung damage group 
In the CD group, intratracheal instillation of Bleomycin 
(Bleocin™, Nippon Kayaku, Japan) was given 56 days before experiment, 
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at a dose of lOU/kg (Berend et al, 1985; Bigby et al, 1985; O'Connor et 
al, 1986). 
Animals were anesthetized with xylazine and ketamine prior to 
intubation and instillation of bleomycin into the lungs via a cuffed 
endotracheal tube (Mallinckrodt medical, Athlone). During instillation, 
the rabbit was rolled from side to side to ensure even distribution of the 
drug in the lungs, and the cuff of the endotracheal tube was left inflated 
for at least 30 min to prevent tracheal clearance of the bleomycin. The 
rabbit was allowed to breathe humidified 100% oxygen for 5 min after the 
intratracheal instillation (Shen et al, 1988). The rabbit was returned to the 
Animal House after it had awakened from anesthesia. They were kept in 
the Animal House until the experiment. 
5. Preparation of the animals for VO2 measurement 
Each animal was anaesthetized with l-1.5ml of ketamine and 
xylazine (7:1) given intramuscularly. A 24-gauge angio-catheter was then 
inserted into the artery of one of the external ears. Anesthesia was 
subsequently maintained by injections of ketamine and xylazine mixture 
at a dose of 0.10-0.15 ml/kg through the ear artery as required. After 
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shaving of the skin, a longitudinal mid-line incision was made along the 
neck to expose the rightjugular vein. A 3.5 French catheter (UNO Metric, 
Demark) flushed with heparin (CP pharmaceuticals, Wrexham UK ) was 
introduced into the vein for about 6-8 cm. By repeated trials and errors in 
animal not used for this study, I have confirmed that this maneuver would 
place the catheter tip in the right atrium. The left carotid artery was then 
exposed and the microprobe containing a temperature sensor (Columbus 
instruments, Ohio, USA) was inserted through the carotid artery into the 
aorta. Again, by repeated trials and errors in practicing sessions, insertion 
ofthe catheter through a standard point at the carotid artery will place the 
tip of the microprobe at the proximal part of the descending aorta. The 
catheter in the right atrium was used for injection of cold saline and blood 
sampling for determination of mixed venous Hb and oxygen saturation. 
The arterial catheter of the external ear was used for blood sampling for 
estimation of arterial Hb and SaO2, and also for continue infusion of 10% 
dextrose at a rate of 1ml per hour. 5-10 injections were performed for 
each rabbit. Less than 10% of thermodilution was excluded before 
calculating the mean cVO2. Single arterial and venous blood samples 
were withdrawn for blood gases on each rabbit. Blood losses due to 
operation and sampling were replaced with the same volume of Normal 
SalineO^g2.^-7). 
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6. Measurement of oxygen consumption 
Oxygen consumption was measured twice, firstly by indirect 
calorimetry using the DeltatracII^^ metabolic monitor (the results 
represented total body oxygen consumpiton including that by the lung 
[VO2wb]). And secondly by the thermodilution method and Fick principle 
using the Cardiomax II cardiac output computer (the results should 
represent the oxygen consumption of the body excluding that of the lungs 
[VO2b]). 
6.1 VO2wb measurement 
All the measurements were obtained with the rabbit breathing 
spontaneously, the rabbit was placed in a specially designed air-tight 
plastic box measuring 55cm x 17.5cm x 15cm {fig 2.4-2). Inspiratory gas 
from the metabolic analyser entered the box through an entry port at the 
head panel and returned to the analyser through an exit port at the end 
panel. Two side-ports near the head end allowed passage of the peripheral 
arterial catheter, the central venous catheter, and the microprobe wire so 
that measurement of cardiac output and blood sampling could be 
performed without opening the box. The side-ports were sealed by several 
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layers of cling film wrapped tightly around the catheters and wire so as to 
prevent any gas leakage. 
Whole body oxygen uptake, CO2 excretion, and the respiratory 
quotient were determined in 1-min intervals with the DeltatracII™ 
metabolic monitor for 15 minutes and the mean value obtained. The 
accuracy of the metabolic monitor in measuring VO2 had been validated 
before and the relative error was only 士 1.9-4o/o (Phang et al, 1990; 
Takala et al, 1989). 
The calorimeter was calibrated before each study with a high-
accuracy calibration gas (mixture of 95% oxygen and 5% CO2) (Datex 
Inst. Corp., Helsinki, Finland). 
6.2 VO2b measurement 
During the measurement of VO2wb, cardiac output was determined 
simultaneously by the thermodilution method using the Cardiomax 
Cardiac Output Monitor (Cardiomax II model 85, Columbus instruments, 
Ohio, USA). The temperature of aortic blood measured by the microprobe 
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0 
was recorded in degree C as a baseline temperature. Subsequently, 0.5-
0.8 ml of ice-cold isotonic saline was introduced into the right atrium 
using an automatic injector (Injector 400，Columbus instruments, Ohio, 
USA) immediately before it was drawn into the syringe of the injector. 
The temperature of the saline was monitored with a thermosensor 
connected to the monitor. To ensure that there was no change in 
temperature of the saline during its passage through the catheter, the 
entire length of the catheter up to its entry into the body box was 
immersed in ice water. The length of the catheter inside the box was 
wrapped in ice by an inner layer of gauze and an outer layer of cling film 
up to its entry into the internal jugular vein. The automatic injector was 
interfaced with the cardiac output monitor to signal the monitor of the 
onset of injection. Immediately after injection of the saline, the change in 
temperature in the aortic blood was continuously monitored and recorded 
by the cardiac output monitor. A temperature dilution curve integrating 
the temperature changes over time and the calculated cardiac output were 
displayed on screen. Only curves that showed an initial fast attack and 
then smoothly roll into an exponential decay were accepted (fig 1.2-2). At 
the same time, arterial and mixed venous blood samples were withdrawn 
from the ear artery and the right atrium respectively. The oxygen 
saturation of the sample was immediately estimated with a blood gas 
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analyser (Chiron Diagnostics, USA). An EDTA sample of each of the 
arterial and venous blood was sent immediately to the Haematology 
Laboratory for measurement of Hb level. Oxygen consumption (VO2b) 
was calculated from the measured values as previously described (see: 
Ch.2, 1.2 Fick method p22.). 
7. Histopathology 
At the end of the experiment, the rabbit was sacrificed with an 
overdose of intravenous pentobarbital sodium. Postmortem chest X-ray 
was performed to confirm that the arterial catheter and the microprobe 
were in good position. The lung was dissected and persevered in 10% 
formalin. 
Lung tissue was embedded in paraffin, and multiple section of 5 
^m thickness was prepared. The sections were stained with Hematoxylin-
eosin and Masson trichrome, and examined under the light microscope. 
Histologic lung injuries were scored using a semiquantitative scoring 
system (King et al, 1995) by a pathologist blinded to the grouping of the 
animals. At magnification x 63 and 250, the degrees of atelectasis, 
congestion, edema, number of neutrophils, hemorrhage hyaline 
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membrane formation and fibrosis formation were separately estimated 
from sections of both interstitium and in the air space of alveolar using 
the following scoring system: none injury = score of 0; mild injury = 
score o f l ; moderate injury = score of 2; severe injury = score of3 . These 
scores were averaged as the histologic lung injuries score for that animal. 
8. Statistics 
All continuous variables are presented as means 士 SD and 
compared among the groups using analysis of variance (ANOVA). When 
a difference is shown, the Bonferroni's test is used for Pairwise 
Comparison. Discrete variables were compared by X^ or Fisher exact test. 
Differences among the groups were considered significant when the a 
error was 5% or less (p< 0.05). 
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A total of forty-four rabbits were entered in this study. There were 
34 male and 10 female rabbits, with Mean (SD) body weight 3.3 (0.5) kg, 
body length 40.3 (2.4) cm, age 19.3 (3.2) weeks. {Table3.1-l) 
1. Healthy (Control) group 
A total of twenty-one rabbits were entered in this group. There 
were twenty male and one female rabbits, with body weight 3.2(0.3) kg, 
body length 39.7(1.8) cm, age 18.3(1.7) weeks. The whole body oxygen 
consumption measured by the Deltatrac (i.e. mVO2) was 26.7(5.6) 
ml/min. During the estimation of VO2wb, their cardiac output measured by 
thermodilution was 664.1(111.1) ml/min. Arterial oxygen saturation and 
haemoglobin concentration were 93.6(7.6)% and 11.2(1.2) g/dl 
respectively. Mixed venous oxygen saturation and haemoglobin 
concentration of the right atrial sample were 67.5(7.7)% and 11.2(1.2) 
g/dl respectively. The calculated oxygen content was 145.3(21.0) ml/L in 
the artery and 105.5(17.5) ml/L in the right atrium. Oxygen consumption 
of the body (VO2b) estimated by the Fick method was 25.8(5.5) ml/L; the 
ratio ofVO2puim to the whole body VO2 was 3.3(2.2)%. 
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1.1 Pulmonary histology 
No pathological changes were noticed in the sections of the lung 
tissues. Normal alveolar structure was seen under light microscope. 
(Table 3.3-l)(Fig3.1-l-3) 
2, Acute lung damage group 
A total of fourteen rabbits were entered in this group. There were 
eight male and six female rabbits, with body weight 3.3 (0.6)kg, body 
length 40.9(2.0) cm, age 19.0(3.4) weeks. The whole body oxygen 
consumption measured by the Deltatrac (i.e. mVO2) was 27.3(6.1) 
ml/min. During the measurement of VO2wb, their cardiac output measured 
by the thermodilution method was 674.6(135.6) ml/min. Oxygen 
saturation and haemoglobin concentration were 95.8(3.1)% and 11.2(1.6) 
g/dl respectively in the artery, and 71.4(5.8)% and 11.5(1.9) g/dl 
respectively in the right atrial sample. The oxygen content was 149.2 
(21.6) ml/min and 111.5 (21.8) ml/min in arterial and right atrial sample, 
respectively. Oxygen consumption of the body (VO2b) estimated by the 




2.1 Pulmonary histology 
The lung histology of the animals in this group showed the 
development of acute interstitial edema with infiltration of neutrophils. 
Examination of representative section shows diffused congestion, edema 
and the formation ofhyaline membranes in the alveolar space. (Table 3.3-
2) {Fig 3.2-1-4) 
3. Chronic lung damage group 
A total of nine rabbits were entered in this group. There were six 
male and three female rabbits, with body weight 3.6(0.5) kg, body length 
40.7(3.6) cm, age 22.1(4.1) weeks. The whole body oxygen consumption 
measured by the Deltatrac (i.e. mVO2) was 30.2(8.0) ml/min. During the 
measurement of VO2wb, their cardiac output was estimated to be 
639.6(118.3) ml/min by thermodilution. Oxygen saturation and 
haemoglobin concentration were 85.5(12.1)% and 13.3(1.2)g/dl 
respectively in the arterial sample, and 64.8(14.1)% and 13.1(1.4) g/dl 
respectively in the right atrial sample. The oxygen content calculated was 
158.1(31.06) and 119.1(30.9) ml/L in the arterial and the right atrial 
samples, respectively. Oxygen consumption of the body (VO2b) as 
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estimated using the Fick principle was 24.2(7.4) ml/L. The ratio of 
VO2puim to the whole bodyVO2 was 20.4(6.3)%. 
3.1 Pulmonary histology 
Marked pathological changes were seen in the lungs of this group 
of animals. There were patchy atelectasis with areas of normal tissue 
alternating with areas of very active inflammation, congestion and 
fibrosis. Other abnormalities included abnormal alveoli with intra-
alveolar accumulation of inflammatory cells. Fibrosis of the parenchymal 
matrix was recognized when the lung sections were stained with Masson 
trichrome {Table 3.3-3) (Fig 3.3-1^3). 
4. Comparison ofthe pulmonary oxygen consumption among 
the three groups 
The pulmonary oxygen consumption (VO2puim), as calculated from 
the difference between VO2b measured by the Fick method and VO2 
measured by the Deltatrac metabolic Monitor was 0.9(0.6) ml/min in the 
healthy controls, 2.5(1.2) ml/min in the acute lung damage group, and 
6.0(2.0) ml/min in the chronic lung damage group. The differences 
among the three groups were statistically significant, as compared by 
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A N O V A (P<0.0001). Multiple Pairwise comparison using the 
Bonferroni's method showed the VO2pui of both the AD and CD group 
was significantly greater than that in the healthy control group. 
When expressed as a proportion of the total body oxygen 
consumption, the VO2puim was 3.3(2.2) % in the healthy controls, 
9.7(5.2)% in the acute lung damage group, and 20.4(6.3) % in the chronic 
lung damage group. The differences among the three groups were again 
statistically significant O^<0.0001, ANOVA). Multiple Pariwise 
comparison using the Bonferroni's method again showed that VO2pui 
constituted a significantly larger proportion of total body VO2 in the AD 
and CD group when compared to the healthy controls. 
Unit VO2 expressed as pulmonary oxygen consumption per 
kilogram (VO2puim, ml/kg/min), was calculated from the difference 
between VO2wb and VO2b divided by the body weight of rabbits. This was 
0.3(0.2) ml/kg/min in the healthy controls. 0.8(0.4) ml/kg/min in the acute 
lung damage group, and 1.7(0.6) ml/kg/min in the chronic lung damage 
group: Multiple Pairwise comparison using the Bonferroni's method 
showed the VO2 per kilogram of both the AD and CD group was 
significantly greater than that in the healthy control group {Tahle 3.1-1). 
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Figure 3.1- Rabbit lung in healthy control group: 
Figure 3.1-1: (Hematoxylin-esoin, x 63) 
Figure 3.1-2: (Masson Trichrome, x 63) 
Figure 3.1 -3: (Hematoxylin-esoin, x 400) 
Sections show normal pulmonary parenchyma. The alveolar septa is thin without 
significant inflammatory cell infiltrate. No increased in interstitial fibrosis is seen 
in the Masson Trichrome stain (figure3.1-2). 
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Figure 3,1-1 (Hematoxylin-esoin, x 63) 
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Figure 3,1-2 (Masson Trichrome, x 63) 
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Figure 3.1-3. (Hematoxylin-eso in, x 400) 
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Figure 3,2- Rabbit lungs in acute damage group (AD). 
Figure 3.2-1: (Hematoxylin-esoin, x 63) 
Figure 3.2-2: (Masson Trichrome, x 63) 
Figure 3.2-3: (Hematoxylin-esoin, x 400) 
Figure 3.2-4: (Hematoxylin-esoin, x 400) 
The low power view {Figure 3.2-1) reveals diffuse infihration by inflammatory 
cells, with expansion of the septa and focal collapse of the alveolar spaces. The 
Masson Trichrome stain (Figure 3.2-2) reveals no significant increase in 
interstitial fibrosis. High power view demonstrates marked increased in 
inflammatory cells consisting ofboth polymorphs and mono-nuclear inflammatory 
cells. Interstitial edema, congestion and haemorrhage are ako evident. Another 
field (Figure 3.2-4) shows similar features of acute damage, as weU as fibrinious 
exudate and inflammatory cells in the alveolar spaces. 
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Figure 3,2-1 (Hematoxylin-esoin, x 63) 
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Figure 3,2-2 (Masson Trichrome x 63) 
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Figure 3,2-3 (Hematoxylin-esoin, x 400) 
^1 mm 
Figure 3.2-4 (Hematoxylin-esoin, x 400) 
79 
Figure 3,3- Rabbit lung in chronic damage (CD) group. 
Figure 3.3-1: ^lematoxylin-esoin, x 63) 
Figure 3.3-2: (Masson Trichrome, x 63) 
Figure 3.3-3: (Hematoxylin-esoin, x 400) 
The low power view (Figure 3.3-1) demonstrates patchy interstitial fibrosis with 
focal increased in inflammatory cells. The fibrosis is highUghted by the Masson 
Trichrome stain {Figure 3J-2). Medial hyperplasia is also noted in the pubnonary 
artery (arrow). The inflammatory cells are mainly composed of mono-nuclear 
inflammatory cells (Figure 3.3-3). 
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Figure 3.3-1 (Hematoxylin-esoin，x 63) 
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Figure 3,3-2 (Masson Trichrome, x 63) 
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Figure 3,3-3 (Hematoxylin-esoin, x 400) 
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Control group AD group CD group P value 
Weight (kg) 3.2i0.3 33+06 3.6i0.5 *P<0.05 
Length (cm) 3 9 . 7土 1 . 8 40.9i2.0 40.7i3.6 NS 
Age (wk) 18.3±1.7 19.0±3.4 22.1i4.1 *P<0.05 
Mean CO jo (ml/min) 664.1illl . l 674.6il35.6 639.6ill8.3 NS 
mean SaO2 (%) 93.6i7.6 95.8±3.1 85.5il2.1 *P<0.05 
aHb (g/dl) 1 1 . 2 ± 1 . 2 1 1 . 2土 1 . 6 1 3 . 3 ± 1 . 2 ^P<0.05 
CaO2 (mUL) 145.3±21.0 149.2i21.6 158.1±31.0 NS 
mean SvO2 (%) 67.5i7.7 71.4i5.8 64.8il4.1 NS 
vHb (g/dl) 11.2±1.0 11.2±1.9 13.1il.4 :P<0.05 
CvO2 (mUL) 105.5il7.5 111.5±21.8 119.1±30.9 NS 
mean cVO2 (ml/min) 25.8i5.5 24.8i6.1 24.2i7.4 NS 
mean mVO2 (ml/min) 26.7±5.6 27.3±6.1 30.2士8.0 NS 
VO2pui (ml/min) 0.9i0.6 2.5±1.2 6.0i2.0 *P<0.05 
VO2pui (ml/kg/min) 0.3±0.2 0 . 8士 0 . 4 1.7±0.6 T<0.001 
VO2pui : VO2wb (0/0) 3.3±2.2 9 . 7土 5 . 2 20.4±6.3 ^P<0.05 
L u n g : Body weight (%) 0.4i0.1 0.4i0.1 0.4士0.0 *P<0.05 
Values are Means 土 SD; n=21 for control group, n=14 and n=9 for A D and C D groups respectively. 
*P< 0.05’ C D > Control group. 
^P< 0.05’ C D group > A D and Control group. 
^ P < 0 . 0 0 1 , A D and C D groups > Control group. 
*'P<0.05, C D > A D > Control group. 
NS: not significance. 
Table 3.1-1 Comparison ofmeasurements obtained by metabolic 
monitor and Fick method in the Control, acute lung damage and chronic 
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Figure 3.4-4 Relationship between VO2pui (ml/min/kg) and severity 





The present study is the first study that compares the local oxygen 
consumption by the lungs in healthy subjects, and subjects with acute and 
chronic lung injury. The findings of this study show that (1) mVO2 
(VO2wb) is greater than cVO2 (VO2b) in all these groups of rabbits, 
including the healthy controls, and (2) the difference between VO2wb and 
VO2b which represents the local oxygen consumption by the lungs, is 
significantly greater in the lung injury groups than in the healthy controls. 
These findings support my hypothesis that (1) oxygen consumption by the 
lung contributes significantly to the total oxygen consumption of the 
body, and (2) lung injury increases local oxygen consumption. 
The determination of VO2 by the Fick method has many potential 
sources of errors because it relies on the measurement of several 
parameters: cardiac output by thermodilution, as well as pulmonary and 
systemic arterial oxygen contents. Because no simple technique can be 
considered a gold standard for cardiac output determination under clinical 
conditions, the problem of assessing the errors of measurement using the 




In in-vitro study, under strictly controlled conditions, the accuracy 
of the thermodilution cardiac output measurement ranges between 士 7 and 
士 13o/o (Thys, 1987). Under clinical conditions, the error in accuracy is 
considered similar, averaging 土 10�/�(Levett & Replogle, 1977; Thys, 
1987)，and relies principally on the accuracy of the injectate volume and 
the use of correct computation constants (for temperature and volume), as 
well as the care of injectate manipulation (e.g. avoiding heating of 
injectate). The use of an automatic injector, the volume and temperature 
of injectate, and the timing of injection in the respiratory cycle may all 
influence precision. 
The Fick method makes the assumption that 1 gram of 
hemoglobin combines with 1.39 ml of oxygen. This assumption is based 
on the molecular weight of hemoglobin (Braunitzer, 1963) and assumes 
that all hemoglobin is in the active form. However, this may not be 
entirely true, since the international standard of hemoglobin estimation is 
based on iron content, not on its actual oxygen-combining capacity, and 
not all of the iron content is in the form of active hemoglobin. Since some 
of the iron is likely to be in the form of haemochromogens, it is not 
altogether surprising that the observed oxygen-combining capacity is less 
than the theoretical value of 1.39ml/g. The oxygen-combining power of 
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hemoglobin has been exhaustively studied by Greogory (Greogory, 
1974), who proposed the values of l .306 ml/g for human adult blood and 
1.312ml/g for fetal blood. But if the value of 1.31 was used instead of 
1.39 in the previous studies, the values ofVO2 measured by the reversed 
Fick procedure would be reduced by about 6% and the difference 
between mVO2 and cVO2 values would be further enhanced. 
We used 1.39 in the present study because it has been accepted for 
New Zealand White rabbit that 1 gram of hemoglobin combines with 
1.39ml of oxygen (Hindman, 1995). On the other hand, the known 
maximum oxygen binding capacity of hemoglobin in rabbit has been 
found to be 1.34-1.39ml/g hemoglobin (Hindman, 1995). In contrast, if 
1.39 is replaced by 1.34 in my study, the values the of cVO2 are lessened 
by about 3.6% and the difference between mVO2 and cVO2 values would 
become even greater (Smithies et al, 1991) and thus would not alter the 
conclusion of my study. 
Another potential error in using the thermodilution method to 
determine cardiac output is the asynchrony in the timing of injection of 
the ice-cold saline into the right atrium and the commencement of 
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temperature measurement by the intra-aortic temperature sensor. In my 
early practice sessions, I injected the saline manually and the cardiac 
output measured fluctuated widely with poor reproducibility. The 
problem was solved by using the automatic injector supplied by the 
manufacturer of the cardiac output monitor. The automatic injector was 
interfaced with the monitor electronically. Temperature measurement was 
activated by injection of the injector, resulting in perfect synchrony of the 
two procedures. 
Warming of the injectate during its passage through the catheter 
might also introduce significant measurement error to the thermodilution 
method. This was overcome by immersing the entire length of the 
catheter in ice water up to its entry into the body box. By wrapping the 
length of the catheter inside the body box in ice further prevented any loss 
in temperature of the injectate. 
On the other hand, two-third of the rabbits in the CD group were 
scored to have atelectasis with congestion, so the lung pathology in the 
CD group might contribute to the presence of intrapulmonary shunts, and 
tricuspid insufficiency. In clinical settings, tricuspid regurgitation 
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frequently occurs in chronic lung problems including that of 
bronchopulmonary dysplasia. This is secondary to the occurrence of 
pulmonary hypertension. The abnormal mixing of blood with injectate 
solution and indicator temperature loss to adjacent tissue secondary to bi-
directional flow from the right ventricular cavity might be the proposed 
cause of inaccuracy. If surrounding tissue fails to release this cold 
injectate prior to the completion of the thermodilution curve integration, 
indicator will not be detected by the thermistor and cardiac output would 
be subsequently overestimated, it seems more likely occurred in the 
rabbits in CD group rather than in AD group. This could be one of 
possible factors that contribute to the elevation of the VO2puim in the 
rabbits with chronic lung disease. 
Former studies have reported that the accuracy of various 
commercial indirect calorimeters generally have a level of accuracy that 
is acceptable for clinical purposes (Braun et al, 1989; Takala et al, 1989; 
Westenskow, Roberts & Pace, 1989; Makita, Nunn & Royston, 1990; 
Svenson, Sonander & Stevqvist, 1990; Smithies et al, 1991). The 
metabolic monitor used in my experiment is a precision instrument with a 
mean error of only 1.9% - 4% in oxygen consumption measurements 
(Takala et al, 1989; Phang et al, 1990). 
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In performing the measurement, I have meticulously minimised 
the error caused by air-leak by using a specially designed air-tight body 
box instead of the canopy provided by the manufacturer. The body box 
has an internal volume similar to that of the neonatal canopy and allows 
blood taking, injection of the injectate, and temperature measurement 
without opening its lid or disturbing the animal. 
With the above precautions to minimise measurement error, I have 
shown that the healthy rabbit lung consumes about 3% of the total-body 
oxygen uptake for its own metabolic requirements. This is very similar to 
former reports that the lung uses 0.7-5% of the total body oxygen 
consumption in human (Frittes et al, 1963; Nunn, 1987; Loer et al, 
l991){TableL3-l). 
The systematic difference between VO2 measured in our animals 
by metabolic monitor and the reversed Fick method could only be 
explained by the VO2 of the lung. 
The lung receives its blood supply from both the bronchial 
circulation derived from aortic blood and the pulmonary circulation. 
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Bronchial blood flows constitutes about 1 -2% of the output of the left 
ventricle. It has a small contribution to pulmonary capillary blood flow 
and gas exchange (Deffebach et al, 1987; Levitzky, 1995). The major 
portion of this blood supplies the bronchial walls and the visceral pleura. 
Pulmonary blood flow constitutes the entire output of the right ventricle, 
which supplies the lung with mixed venous blood draining from all the 
tissues of the body. This is the blood that undergoes gas exchange with 
the alveolar air in the pulmonary capillaries. Therefore, it is not surprising 
that the alveolar walls derive oxygen chiefly from the alveolar air, 
whereas the bronchi, the smaller air passages, and the major portions of 
the visceral pleura utilise the oxygen carried by the bronchial flow 
(Bloomer et al’ 1949; Lilker & Nagy, 1975). The cVO2 calculated by the 
Fick principle measures oxygen uptake by the body before its blood 
enters the lungs and the VO2 estimated represents the oxygen 
consumption of the body (VO2b) without the lung. On the other hand, 
since the mVO2 is measured by way of the respiratory gases, the 
measured volume represents VO2 of whole body (VO2wb), including the 
lungs. Therefore, the difference between mVO2 and cVO2 should indicate 
the amount of oxygen consumed by the lungs (VO2puim): 
mVO2 - cVO2 = VO2puim 
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One of the studies performed by Loer and coworkers estimated the 
lung oxygen consumption in patients undergoing open heart surgery for 
coronary bypass grafting or valvular replacement. During total 
cardiopulmonary bypass, all blood from the caval veins was drained into 
the cardiotomy reservoir and the caval veins were occluded by banding so 
that pulmonary artery flow ceased completely. The left ventricle was 
vented. Blood was oxygenated and regulated by a membrane oxygenator 
and a roller pump respectively. Systemic hypothermia of 28®C was 
induced by blood cooling and maintained for at least 30 minute. During 
this period, the lungs were ventilated with low tidal volumes and positive 
end-expiratory pressure. Oxygen consumption was estimated by 
respiratory gas analysis, assuming that pulmonary gas exchange was 
completely separated from body gas exchange during measurement (Loer 
et al, 1997). Total lung oxygen consumption might have been 
underestimated because of the unknown magnitude of the bronchial 
circulation under such circumstances. The absolute quantity of 
transpleural diffusion varies with the magnitude of the concentration 
gradients, and Loer used 50% oxygen for both ventilating the lung and 
oxygenating the blood during total cardiopulmonary bypass. Hence the 
transpleural partial pressure gradient for oxygen was minimised, limiting 
the gas exchange with ambient air. Moreover, Loer's study consisted 
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mainly of elderlies with marked cardiac disease, requiring different type 
of open-chest operation and positive end-expiratory pressure ventilation, 
which might have affected the oxygen consumption of the lung. 
Atelectasis of the lung during open-chest operation, who had an 
significant effect on the lung's metabolism and oxygen requirement 
(Hachenberg et al, 1994). Thus, the finding of this study were difficult to 
interpret as they certainly did not represent the normal healthy subjects or 
subjects with any particular type of lung decreases. In contrast, our 
animal study provided assessments of VO2pui in vivo without any major 
external factors that might affect lung metabolism, and the finding were 
unlikely to have been affected by measurement errors due to the 
contributions by transpleural diffusion, bronchial circulation, 
development of atelectasis or the absence ofpulmonary artery flow. 
Our finding provide the first direct comparison of the oxygen 
consumption of the healthy and diseased lungs. Compared to the healthy 
control group, the pulmonary oxygen consumption was significantly 
increased from 3.3士 2.2o/o to 9.7 士 5.2 % and 20.4 土 6.3 % in the acute 
and chronic lung damage groups respectively. The among of pulmonary 
oxygen consumption by diseased lungs was similar to that reported in 
previous studies on both human and animals with pulmonary injuries 
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(Fritts et al, 1963; Takala et al, 1989; Becq et al, 1992; Bizouam et al, 
1992; Loer, 1997). 
In a canine model of experimental pneumococcal pneumonia, 
Light (Light, 1988) demonstrated that the VO2pui was 13-15% of VO2wb. 
A number ofhuman studies, mostly in adult patients with ARDS (Kox & 
Chirst, 1991)，sepsis and respiratory failure (Smithies et al, 1991), cardiac 
surgeries (Oudemans-van et al, 1993; Takala et al, 1989)，or acute lung 
injury (Jolliet et al, 1996), have all provided evidence that VO2pui could 
constitutes a significant proportion of body oxygen consumption when 
there is significant lung injury (Fritts et al, 1961, 1963; Levinson et al, 
1987; Takala et al, 1989; Chopin et al, 1990; Smithies et al, 1991, 1992; 
Becq et al, 1992; Bizouam et al, 1992; Myburgh et al, 1992; Oudemans-
van et al, 1993; Chiolero et al’ 1994). In these studies VO2pui varied from 
14 - 40% of V02wb- The most likely reason for the increase of VO2pui in 
lung-injured subjects is the presence ofpulmonary inflammatory response 
(Kirklin et al, 1983; Oeveren et al, 1985). In our lung-damaged animals, 
lung section showed an abundance of neutrophils and macrophage in the 
interstitium. Both neutrophils and macrophages undergo oxidative 
metabolism, which increases when the cells perform phagocytosis during 
inflammations. Moreover, neutrophils show an enormous increase in 
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oxygen consumption during the "oxygen burst" associated with the 
formation of oxygen-derived free radicals. Thus inflammation in the 
lungs inevitably increase the organ's oxygen consumption, as observed in 
our animals in the lung- damaged groups (Nunn, 1996). 
In both our AD and CD group of animals, histopathological 
examination revealed inflammatory changes ofmoderate to severe degree 
damage. The histopathological changes in our AD group of rabbits 
consisted of acute inflammatory responses in both the interstitium and the 
air space including congestion, edema, infiltration of neutrophils and 
hyaline membrane formation. Their changes were similar to those 
reported previously for NNNMU-induced lung damage (Finley, Swenson 
& Comroe, 1962; Ryan, Loomis & Barrett, 1976; Ryan et al, 1981; 
Haselton, 1983; Liau et al, 1987; Harris et al, 1989; Harriset et al, 1989; 
Lewis, Ikegami & Jobe，1990). The changes closely resembled those in 
the lungs of patients with early stages of ARDS, with profound alveolar 
damage (Ashbaugh et al, 1967; Petty et al, 1977, 1979; Mason, 1987; 
Petty, 1990; Gregory et al, 1991). 
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The morphologic changes in the lungs of the CD group displayed 
marked chronic changes in the interstitium with atelectasis, infiltration by 
inflammatory cells, and fibrosis. The changes were similar to those 
observed in rodents that displayed chronic inflammatory process and 
interstitial pneumonitis featured by fibrosis (Adamson & Bowden，1974; 
Aso, Yoneda & Kiklawa，1976; Comis, 1978). 
In my experiments, despite the increase in VO2pui, the total body 
VO2 of animals in the AD and CD group were higher than that of the 
control group although the difference was not statistically significant. 
Their body weight and growth rate did not appear to be impaired. 
Theoretically, organ injuries should increase oxygen requirement 
to satisfy the need for tissue repair and recovery. In canines with 
pneumonia, Light (Light, 1988) reported that the whole body oxygen 
consumption, measured by collection of expired gas was considerably 
increased. 
The lack of statistically significant difference is V 0 2 between our 
healthy and diseased rabbits could be due to the relatively small and lack 
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of power of the sample size. One other possible explanation for this 
discrepancy may be the mechanism of lung damage. In Light's study, 
lung injury was induced in dogs by infecting the lungs with Streptococcus 
pneumoniae. The oxygen uptake by the bacteria, along with the 
destruction of the lung, could have contributed to the increase in VO2wb. 
The lung damage in our animals was induced by chemical destruction 
without the use of bioactive agents. This might have contributed to a 
lesser degree of increment in overall oxygen consumption of the body. 
Moreover, it has been previously reported that both the growth rate and 
the body weight had remained unchanged in rabbits receiving as much as 






Growth failure is a common and difficult management problem in 
infants with chronic lung disease. Current treatment consists mainly of 
nutritional supplementation, and the use of bronchodilators to reduce the 
work ofbreathing. My study provides evidence that a significant increase 
in the oxygen consumption and energy expenditure by the inflamed lungs 
might be an important contributing factor. Therapies aiming at 
suppressing lung inflammation might be a logical approach in managing 
CLD infants with growth failure. 
My study showed that in the healthy state, adult rabbit lung 
consumed about 3% of the total oxygen consumption of the body. 
Oxygen consumption by the lung was increased significantly in the 
presence of either acute or chronic lung injury. This was likely to be 
related to the result of inflammatory changes such as cellular infiltration. 
In my experiment, a new animal model not considered in previous 
studies was introduced. We have demonstrated that there were reflections 
of morphological damages with acute and chronic inflammatory changes, 
which might be potentially comparable to preterm human infants with 
chronic lung disease, for example, bronchopulmonary dysplasia (BPD). 
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Further works need to be done to clearly characterize these 
pathological alterations, in order to introduce a most suitable model for 





As already discussed, this is the first study compares the local 
oxygen consumption by the lung in healthy subjects and subjects with 
acute and chronic lung injury. Based on the findings and the 
established methodology of this study, a number of areas could be 
considered for further exploration. 
Though we have demonstrated the morphological damages with 
acute and chronic inflammatory changes, more works need to be done 
to clearly identify the precise pathway of the pathological alterations. 
In particular, the surfactant and cytokines involved, as well as the 
comparability of this model to the preterm human infants with BPD 
are all need to be further investigated. This is especially important 
because with the improvement of the technology and facilities of the 
NICUs, the survival rate of prematurity infants is increasing, as well 
as the incidence of BPD. Similarly, it represents an area that could be 
exploited for the utilization of a new animal model. 
In addition, it is worthwhile to see whether administration of 
steroid or other anti-inflammation medications to subjects with lung 
damage (e.g. CLD) would reduce their oxygen consumption and 
improve their growth. Non-steroid anti-flammatory drugs are of 
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particular interest since unlike steroid, they do not have any know 
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